Healthcare provider profile · identity verified

Eugene D Pogorelec

Family Practice · MASSILLON, OH · NPI 1134114036

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	506	146
Omeprazole	Omeprazole	229	66
Amlodipine Besylate	Amlodipine Besylate	213	66
Tamsulosin Hcl	Tamsulosin Hcl	176	55
Atorvastatin Calcium	Atorvastatin Calcium	161	53
Losartan Potassium	Losartan Potassium	161	51
Prednisone	Prednisone	159	98
Potassium Chloride	Potassium Chloride	155	54
Metoprolol Succinate	Metoprolol Succinate	152	50
Diclofenac Sodium	Diclofenac Sodium	146	43
Metoprolol Tartrate	Metoprolol Tartrate	140	40
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	134	33
Famotidine	Famotidine	133	44
Escitalopram Oxalate	Escitalopram Oxalate	124	39
Fenofibrate	Fenofibrate	119	30
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	118	44
Pantoprazole Sodium	Pantoprazole Sodium	116	43
Alprazolam	Alprazolam	115	41
Lisinopril	Lisinopril	115	38
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	105	30
Furosemide	Furosemide	104	37
Doxycycline Hyclate	Doxycycline Hyclate	100	73
Montelukast Sodium	Montelukast Sodium	90	27
Glimepiride	Glimepiride	83	26
Rosuvastatin Calcium	Rosuvastatin Calcium	81	29
Metolazone	Metolazone	80	27
Sulindac	Sulindac	73	27
Clopidogrel	Clopidogrel Bisulfate	72	23
Gabapentin	Gabapentin	72	24
Simvastatin	Simvastatin	69	23
Eliquis	Apixaban	66	18
Lorazepam	Lorazepam	61	23
Bupropion Hcl Sr	Bupropion Hcl	58	17
Esomeprazole Magnesium	Esomeprazole Magnesium	54	16
Metformin Hcl	Metformin Hcl	54	18
Topiramate	Topiramate	52	11
Albuterol Sulfate Hfa	Albuterol Sulfate	51	14
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	47	14
Meloxicam	Meloxicam	45	15
Hydrochlorothiazide	Hydrochlorothiazide	43	15
Ondansetron Hcl	Ondansetron Hcl	42	18
Xarelto	Rivaroxaban	42	suppressed
Jardiance	Empagliflozin	39	suppressed
Doxepin Hcl	Doxepin Hcl	36	14
Ipratropium Bromide	Ipratropium Bromide	35	17
Alfuzosin Hcl Er	Alfuzosin Hcl	33	suppressed
Allopurinol	Allopurinol	33	suppressed
Cephalexin	Cephalexin	33	31
Duloxetine Hcl	Duloxetine Hcl	32	12
Janumet	Sitagliptin Phos/Metformin Hcl	32	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	32	11
Tizanidine Hcl	Tizanidine Hcl	32	14
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	31	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	31	suppressed
Buspirone Hcl	Buspirone Hcl	30	14
Probenecid-Colchicine	Probenecid/Colchicine	29	suppressed
Citalopram Hbr	Citalopram Hydrobromide	28	suppressed
Tramadol Hcl	Tramadol Hcl	28	17
Sertraline Hcl	Sertraline Hcl	27	suppressed
Spironolactone	Spironolactone	27	suppressed
Carvedilol	Carvedilol	26	suppressed
Trazodone Hcl	Trazodone Hcl	26	suppressed
Valacyclovir	Valacyclovir Hcl	25	14
Celecoxib	Celecoxib	24	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	24	15
Estradiol	Estradiol	24	suppressed
Propranolol Hcl	Propranolol Hcl	24	suppressed
Atenolol	Atenolol	23	suppressed
Clonidine Hcl	Clonidine Hcl	23	suppressed
Clindamycin Hcl	Clindamycin Hcl	22	18
Fluconazole	Fluconazole	22	18
Ibuprofen	Ibuprofen	22	suppressed
Ropinirole Hcl	Ropinirole Hcl	22	suppressed
Warfarin Sodium	Warfarin Sodium	22	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	21	suppressed
Metformin Hcl Er	Metformin Hcl	21	suppressed
Telmisartan	Telmisartan	21	suppressed
Bupropion Xl	Bupropion Hcl	20	suppressed
Ozempic	Semaglutide	20	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	19	suppressed
Finasteride	Finasteride	18	suppressed
Lovastatin	Lovastatin	18	suppressed
Meclizine Hcl	Meclizine Hcl	18	suppressed
Pravastatin Sodium	Pravastatin Sodium	18	suppressed
Vascepa	Icosapent Ethyl	18	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	18	suppressed
Enalapril Maleate	Enalapril Maleate	17	suppressed
Glipizide	Glipizide	17	suppressed
Lamotrigine	Lamotrigine	17	suppressed
Nebivolol Hcl	Nebivolol Hcl	17	suppressed
Nitroglycerin	Nitroglycerin	16	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	16	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Terazosin Hcl	Terazosin Hcl	15	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	15	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	14	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	11
Clonazepam	Clonazepam	14	suppressed
Jentadueto	Linagliptin/Metformin Hcl	14	suppressed
Levofloxacin	Levofloxacin	14	13
Nortriptyline Hcl	Nortriptyline Hcl	14	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	14	suppressed
Synjardy	Empagliflozin/Metformin Hcl	14	suppressed
Amiodarone Hcl	Amiodarone Hcl	13	suppressed
Dutasteride	Dutasteride	13	suppressed
Glyxambi	Empagliflozin/Linagliptin	13	suppressed
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Pregabalin	Pregabalin	13	suppressed
Terbinafine Hcl	Terbinafine Hcl	13	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	11
Baclofen	Baclofen	12	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Diazepam	Diazepam	12	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	12	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	suppressed
Alendronate Sodium	Alendronate Sodium	11	suppressed
Cimetidine	Cimetidine	11	suppressed
Dexlansoprazole Dr	Dexlansoprazole	11	suppressed
Digoxin	Digoxin	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Januvia	Sitagliptin Phosphate	11	suppressed
Ramipril	Ramipril	11	suppressed
Torsemide	Torsemide	11	suppressed
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error